This list represents the multi-disciplinary team expertise of Penn Medicine clinicians who specialize in a unified program for both GEP-NET and PHEOs/PARAs. Penn Medicine's comprehensive program is focused on the accurate diagnosis, staging and treatment of neuroendocrine cancers. We have two specialized nurse navigators to help you find the right treatment team for your needs.
Mark Stephen Etherington, MD
Douglas L. Fraker, MD
Robert E. Roses, MD
Heather Wachtel, MD, FACS
Anastassia Amaro, MD
Julia Kharlip, MD
Caitlin A. White, MD
Galen Leung, MD
Daniel M. DePietro, MD
Michael C. Soulen, MD
Maria Bonanni, MSN, CRNP
Katherine L. Nathanson, MD
Anna Raper, MS, CGC
Mersedeh Rohanizadegan, MD, MPH
Nevena Damjanov, MD
Jennifer R. Eads, MD
Ryan C. Massa, MD
Vivek K. Narayan, MD, MS
Charles J. Schneider, MD, FACP
Aditi P. Singh, MD
Ursina R. Teitelbaum, MD
Devraj Basu, MD, PhD, FACS
Douglas C Bigelow, MD
Robert M. Brody, MD
Ryan M. Carey, MD
Christopher H. Rassekh, MD
Zhaohai Yang, MD, PhD
Michelle Alonso-Basanta, MD, PhD
Keith Cengel, MD, PhD
Harper Hubbeling, MD
Emily Schapira Lebow, MD
Brianna E. Reardon, CRNP
David A. Mankoff, MD, PhD
Daniel Pryma, MD
Debbie Cohen, MD
Jordana B. Cohen, MD, MSCE
Proton therapy is a non–invasive, incredibly precise cancer treatment that uses a beam of protons moving at very high speeds to destroy cancer cells.
Our experienced cancer nurses and referral staff are here to help. Call 800-789-7366 (PENN) or complete an online request.
Learn more about the benefits of translational research at Penn Medicine.